Personalized medicine for chronic, complex diseases: chronic obstructive pulmonary disease as an example

Personalized Medicine
Josiah E RadderAnnerose Berndt

Abstract

Chronic, complex diseases represent the majority of healthcare utilization and spending in the USA today. Despite this, therapeutics that account for the heterogeneity of these diseases are lacking, begging for more personalized approaches. Improving our understanding of disease phenotypes through retrospective trials of electronic health record data will enable us to better categorize patients. Increased usage of next-generation sequencing will further our understanding of the genetic variants involved in chronic disease. Utilization of data warehousing will be necessary in order to securely handle, integrate and analyze the large sets of data produced with these methods. Finally, increased use of clinical decision support will enable the return of clinically actionable results that physicians can use to apply these personalized approaches.

References

Feb 1, 1978·European Journal of Biochemistry·J O JeppssonM Fagerhol
May 1, 1970·Annals of Internal Medicine·R K LarsonH H Fudenberg
May 29, 1998·American Journal of Respiratory and Critical Care Medicine·R J GivelberG T O'Connor
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Dec 25, 1964·Science·F KUEPPERSA G BEARN
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Jul 29, 2004·American Journal of Respiratory and Critical Care Medicine·Peter M A Calverley
Sep 17, 2004·Medical Informatics and the Internet in Medicine·D Karlsson, U Forsum
Nov 23, 2005·The Pharmacogenomics Journal·B S Shastry
Jan 3, 2006·The European Respiratory Journal·K R ChapmanR Beasley
Dec 17, 2009·Nature Genetics·Emmanouela RepapiMartin D Tobin
Jan 16, 2010·The European Respiratory Journal·P-R BurgelUNKNOWN Initiatives BPCO Scientific Committee
Mar 11, 2010·COPD·Elizabeth A ReganJames D Crapo
Mar 20, 2010·Pharmacogenomics·Laurent Becquemont
Apr 7, 2010·American Journal of Human Genetics·Marylyn D RitchieDan M Roden
Jun 5, 2010·American Journal of Respiratory and Critical Care Medicine·MeiLan K HanFernando J Martinez
Jul 22, 2010·The New England Journal of Medicine·David Blumenthal, Marilyn Tavenner
Aug 17, 2010·American Journal of Respiratory and Critical Care Medicine·Xiangyang KongUNKNOWN ECLIPSE Study NETT Investigators
Feb 19, 2011·American Journal of Respiratory and Critical Care Medicine·Craig P HershThomas J Mariani
Apr 22, 2011·Science Translational Medicine·Abel N KhoJoshua C Denny
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Aug 27, 2011·Genome Biology·Andrea SbonerMark B Gerstein
Nov 15, 2011·Human Molecular Genetics·Michael H ChoUNKNOWN COPDGene Investigators
Dec 6, 2011·Human Molecular Genetics·Xiaobo ZhouEdwin K Silverman
Jan 17, 2012·American Journal of Human Genetics·Peter M VisscherJian Yang
Jan 19, 2012·Nature Reviews. Genetics·Greg Gibson
Mar 24, 2012·Journal of Surgical Oncology·John EberhardtAlexander Stojadinovic
Apr 17, 2012·Human Mutation·Peter N Robinson
Jul 19, 2012·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·L V WainM D Tobin
Oct 24, 2012·EMBO Molecular Medicine·Annerose BerndtSteven D Shapiro
Nov 3, 2012·Thorax·Alvar Agusti, William MacNee
Dec 6, 2012·Clinical Pharmacology and Therapeutics·E K Silverman, J Loscalzo
Dec 12, 2012·Current Opinion in Allergy and Clinical Immunology·Matthias WjstMatthias Arnold
Mar 5, 2013·European Respiratory Review : an Official Journal of the European Respiratory Society·Ian P Hall
Mar 16, 2013·JAMA : the Journal of the American Medical Association·Justin StarrenErwin P Bottinger
Mar 21, 2013·Multidisciplinary Respiratory Medicine·Enrica BertellaUNKNOWN General Practitioners Distretto 04 ASL 02 Brescia, Italy
May 4, 2013·Lancet·Jack CuzickUNKNOWN SERM Chemoprevention of Breast Cancer Overview Group
May 15, 2013·Current Medical Research and Opinion·Daniel BellettiJenifer Wogen

❮ Previous
Next ❯

Citations

Sep 1, 2014·Personalized Medicine·George P Patrinos, Barbara Prainsack
Dec 19, 2019·Periodontology 2000·James D BeckSteven Offenbacher
Apr 15, 2020·Clinical Chemistry and Laboratory Medicine : CCLM·Francesco Salvatore
Sep 15, 2016·Annals of the New York Academy of Sciences·Joseph Finkelstein, In Cheol Jeong

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

COPDGene
eMERGE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacology and Therapeutics
H Derendorf
Canadian Journal of Public Health = Revue Canadienne De Santé Publique
R Labonte
© 2022 Meta ULC. All rights reserved